Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Swanson

Showing results (1261-1270 of 1,331) with videos related to

Pageof 134
Sort By:
Neuro-Oncology Advances|February 10, 2026
Outcomes of patients with melanoma brain metastases treated with ipilimumab and nivolumab with or without upfront comprehensive stereotactic radiosurgeryTroy J Kleber, Denái R Milton, Subhiksha Srinivasan, et al.
Science Translational Medicine|April 6, 2023
Rational design of a highly immunogenic prefusion-stabilized F glycoprotein antigen for a respiratory syncytial virus vaccineYe Che, Alexey V Gribenko, Xi Song, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 1, 2016
The genetic basis of classic nonketotic hyperglycinemia due to mutations in GLDC and AMTCurtis R Coughlin, Michael A Swanson, Kathryn Kronquist, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 5, 2018
Correction: The genetic basis of classic nonketotic hyperglycinemia due to mutations in GLDC and AMTCurtis R Coughlin, Michael A Swanson, Kathryn Kronquist, et al.
JAMA|September 3, 2025
Transparent Reporting of Observational Studies Emulating a Target Trial-The TARGET StatementAidan G Cashin, Harrison J Hansford, Miguel A Hernán, et al.
British Journal of Pharmacology|February 19, 2017
Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseasesNathan A Berger, Valerie C Besson, A Hamid Boulares, et al.
NPJ Vaccines|July 6, 2026
Preclinical immunogenicity of the LP.8.1-adapted BNT162b2 COVID-19 vaccineChaitanya Kurhade, Wei Chen, Weiqiang Li, et al.
BMJ (Clinical Research Ed.)|September 3, 2025
Transparent reporting of observational studies emulating a target trial: the TARGET StatementAidan G Cashin, Harrison J Hansford, Miguel A Hernán, et al.
The Journal of Nutrition|May 4, 2012
Summary of an NIH workshop to identify research needs to improve the monitoring of iodine status in the United States and to inform the DRIChristine A Swanson, Michael B Zimmermann, Sheila Skeaff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2004
Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter studyJean-Jacques Patard, Hyung L Kim, John S Lam, et al.
Pageof 134

Showing results (1261-1270 of 1,331) with videos related to

Sort By:
Pageof 134
Neuro-Oncology Advances|February 10, 2026
Outcomes of patients with melanoma brain metastases treated with ipilimumab and nivolumab with or without upfront comprehensive stereotactic radiosurgeryTroy J Kleber, Denái R Milton, Subhiksha Srinivasan, et al.
Science Translational Medicine|April 6, 2023
Rational design of a highly immunogenic prefusion-stabilized F glycoprotein antigen for a respiratory syncytial virus vaccineYe Che, Alexey V Gribenko, Xi Song, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 1, 2016
The genetic basis of classic nonketotic hyperglycinemia due to mutations in GLDC and AMTCurtis R Coughlin, Michael A Swanson, Kathryn Kronquist, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 5, 2018
Correction: The genetic basis of classic nonketotic hyperglycinemia due to mutations in GLDC and AMTCurtis R Coughlin, Michael A Swanson, Kathryn Kronquist, et al.
JAMA|September 3, 2025
Transparent Reporting of Observational Studies Emulating a Target Trial-The TARGET StatementAidan G Cashin, Harrison J Hansford, Miguel A Hernán, et al.
British Journal of Pharmacology|February 19, 2017
Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseasesNathan A Berger, Valerie C Besson, A Hamid Boulares, et al.
NPJ Vaccines|July 6, 2026
Preclinical immunogenicity of the LP.8.1-adapted BNT162b2 COVID-19 vaccineChaitanya Kurhade, Wei Chen, Weiqiang Li, et al.
BMJ (Clinical Research Ed.)|September 3, 2025
Transparent reporting of observational studies emulating a target trial: the TARGET StatementAidan G Cashin, Harrison J Hansford, Miguel A Hernán, et al.
The Journal of Nutrition|May 4, 2012
Summary of an NIH workshop to identify research needs to improve the monitoring of iodine status in the United States and to inform the DRIChristine A Swanson, Michael B Zimmermann, Sheila Skeaff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2004
Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter studyJean-Jacques Patard, Hyung L Kim, John S Lam, et al.
Pageof 134